about
Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverDrug-induced liver injury: recent advances in diagnosis and risk assessment.Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases.The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.PharmGKB summary: isoniazid pathway, pharmacokinetics.A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
P2860
Q26800213-091F882D-58FF-41BD-8A93-647FEBCE3C29Q30235089-407E2909-DCAD-453D-8BD1-2CFFBBDF321DQ36590615-63B5A2F0-983A-4D95-8BEA-33572756FF2FQ38658553-4B72ADE8-A866-48C0-9EDA-0DAFA87C5A0AQ41928784-CDA2FB3E-19C5-4BFA-9EE8-D3406157E8FBQ42090708-18C255DE-EFC8-477D-8BB5-567556B1BE61Q46377624-D5CBDCB7-6695-42E1-A800-2238075A5012
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CYP2E1 autoantibodies in liver diseases
@en
type
label
CYP2E1 autoantibodies in liver diseases
@en
prefLabel
CYP2E1 autoantibodies in liver diseases
@en
P2860
P921
P1433
P1476
CYP2E1 autoantibodies in liver diseases
@en
P2093
Cristina Rigamonti
Matteo Vidali
P2860
P356
10.1016/J.REDOX.2014.11.004
P577
2014-11-18T00:00:00Z